METTL3-Mediated m6A Modification of ISG15 mRNA Regulates Doxorubicin-Induced Endothelial Cell Apoptosis

Dongdong Jian1,2, Han Li3,4, Chenqiu Wang3

  • 1Department of Biochemistry and Molecular Biology, Beijing Key Laboratory of Protein Posttranslational Modifications and Cell Function, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.

Insights

Methyltransferase-like 3 (METTL3) protects against doxorubicin-induced vascular injury by methylating interferon-stimulated gene 15 (ISG15) RNA. This m6A modification reduces ISG15 levels, preventing endothelial cell apoptosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • N6-adenosine methylation (m6A) regulates diverse biological processes and diseases.
  • The role of m6A in chemotherapy-induced vascular endothelial injury remains unclear.

Purpose of the Study:

  • To investigate the role of methyltransferase-like 3 (METTL3) in doxorubicin (DOX)-induced vascular endothelial injury.
  • To elucidate the molecular mechanism by which METTL3 affects endothelial cell apoptosis.

Main Methods:

  • In vivo and in vitro models of DOX-induced vascular endothelial injury.
  • Transcriptome and proteome sequencing.
  • Methylated RNA immunoprecipitation (meRIP)-qPCR and mRNA stability assays.
  • Gene silencing techniques (METTL3 and ISG15).

Main Results:

  • METTL3 expression decreased in DOX-treated vascular endothelial cells, exacerbating apoptosis.
  • METTL3 silencing led to increased interferon-stimulated gene 15 (ISG15) mRNA and protein levels.
  • METTL3 directly methylated ISG15 RNA at site 1,014,147, reducing ISG15 mRNA stability.
  • ISG15 knockdown attenuated DOX-induced endothelial cell apoptosis and dysfunction.

Conclusions:

  • METTL3-mediated m6A modification of ISG15 mRNA is a key mechanism in DOX-induced endothelial cell apoptosis.
  • METTL3-ISG15 pathway represents a potential therapeutic target for chemotherapy-associated vascular injury.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K